Copyright
©The Author(s) 2023.
World J Meta-Anal. Apr 18, 2023; 11(4): 102-111
Published online Apr 18, 2023. doi: 10.13105/wjma.v11.i4.102
Published online Apr 18, 2023. doi: 10.13105/wjma.v11.i4.102
Indication | Current evidence |
Sexual dysfunction | Equivocal[6] |
Infertility | Equivocal[13] |
Genitourinary symptoms (alternative agent) | Positive[7,9] |
Peri-menopausal and menopausal women | Equivocal[5] |
Adrenal insufficiency (alternative agent) | Positive[17] |
Anorexia nervosa | Equivocal[19] |
Autoimmune diseases | Equivocal[24,27] |
Musculoskeletal | Equivocal[43] |
Neuropsychiatric diseases | Equivocal[48] |
Anti-ageing agent | Negative[35,36] |
Cardiovascular disorders | Equivocal[54,55] |
- Citation: Jethwani P, Rastogi A, Shukla R. Dehydroepiandrosterone sulfate supplementation in health and diseases. World J Meta-Anal 2023; 11(4): 102-111
- URL: https://www.wjgnet.com/2308-3840/full/v11/i4/102.htm
- DOI: https://dx.doi.org/10.13105/wjma.v11.i4.102